HADHA
protein-codinghydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
Gene summary
This gene encodes the alpha subunit of the mitochondrial trifunctional protein, which catalyzes the last three steps of mitochondrial beta-oxidation of long chain fatty acids. The mitochondrial membrane-bound heterocomplex is composed of four alpha and four beta subunits, with the alpha subunit catalyzing the 3-hydroxyacyl-CoA dehydrogenase and enoyl-CoA hydratase activities. Mutations in this gene result in trifunctional protein deficiency or LCHAD deficiency. The genes of the alpha and beta subunits of the mitochondrial trifunctional protein are located adjacent to each other in the human genome in a head-to-head orientation. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~54.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012173
Submitter: ClinGen
*HADHA* was first reported in relation to autosomal recessive long chain 3-hydroxyacyl-CoA dehydrogenase deficiency in 1994 (IJlst et al., PMID: 7811722). Seven variants (missense, nonsense, frameshift) that have been reported in 10 probands in 4 publications (PMIDs: 7811722, 10518281, 21103935, 9739053) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts) has been reached. Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency is characterized by early-onset cardiomyopathy, hypoglycemia, neuropathy, and retinopathy. The disease mechanism appears to be biallelic loss of function. Heterozygous carriers are reportedly unaffected. This gene-disease relationship is also supported by a mouse model (PMID:11390422) and functional assays in patient cells showing reduced long-chain 3-hydroxyacyl-CoA dehydrogenase activity (PMID: 8770876). In summary, there is definitive evidence supporting the relationship between *HADHA* and autosomal recessive long chain 3-hydroxyacyl-CoA dehydrogenase deficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Fatty Acid Oxidation Disorders GCEP on February 12th, 2018 (SOP Version 6).
Inheritance Pattern: AR
Disease ID:MONDO:0012172
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012173
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012173
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0012173
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012172
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0958181
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012173
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012173
Submitter: Natera
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Biochemical
Rationale: Early diagnosis to allow interventions such as avoidance of fasting and urgent metabolic care in the setting of acute metabolic decompensation can reduce morbidity and mortality; Medical management (such as with triheptanoin) has been described as beneficial
Comments: Variants are also related to maternal HELLP syndrome and Acute fatty liver of pregnancy
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HADHA variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000182.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 12 | 305 | 317 | |||
| missense | 3 | 25 | 238 | 22 | 2 | 290 |
| nonsense | 24 | 29 | 1 | 54 | ||
| start loss | 2 | 2 | ||||
| frameshift | 67 | 76 | 1 | 144 | ||
| splice donor/acceptor (+/-2bp) | 10 | 42 | 6 | 58 | ||
| Total | 104 | 174 | 258 | 327 | 2 | 865 |
Highest pathogenic variant AF is 0.0013409166
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000173.2 | 20 | MANE Select | |
| Ensembl | ENSP00000370023.3 | 20 | MANE Select | |
| Ensembl | ENSP00000438039.2 | 19 | Standard | |
| Ensembl | ENSP00000438039.2 | 19 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Tryptophan metabolism - Homo sapiens (human)
- Butanoate metabolism - Homo sapiens (human)
- beta-Alanine metabolism - Homo sapiens (human)
- Lysine degradation - Homo sapiens (human)
- Propanoate metabolism - Homo sapiens (human)
Biological Process
- fatty acid beta-oxidation
- response to insulin
- response to drug
Molecular Function
- fatty-acyl-CoA binding
- 3-hydroxyacyl-CoA dehydrogenase activity
- acetyl-CoA C-acetyltransferase activity
- enoyl-CoA hydratase activity
- protein binding
Cellular Component
- mitochondrion
- mitochondrial inner membrane
- mitochondrial fatty acid beta-oxidation multienzyme complex
- mitochondrial nucleoid
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000380649
- Coding exons
- 20
- Length
- 54091
- Individuals with no LoFs
- 125668
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 80
- Defined
- 125748
- p
- 0.000318
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.821 | 355 | 401 | 0.885 | 0.0000218 | 4942 |
| Missense (PolyPhen) | 119 | 163.63 | 0.72726 | 2019 | ||
| Synonymous | -0.580 | 161 | 152 | 1.06 | 0.00000880 | 1532 |
| Loss of Function | 3.43 | 16 | 39.1 | 0.409 | 0.00000204 | 500 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00038 | 0.00038 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00038 | 0.00035 | rare |
| South Asian | 0.00052 | 0.00052 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Bifunctional subunit.;
- Disease
- DISEASE: Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]: A disease biochemically characterized by loss of all enzyme activities of the mitochondrial trifunctional protein complex. Variable clinical manifestations include hypoglycemia, cardiomyopathy, delayed psychomotor development, sensorimotor axonopathy, generalized weakness, hepatic dysfunction, respiratory failure. Sudden infant death may occur. Most patients die from heart failure. {ECO:0000269|PubMed:9739053}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Long-chain 3-hydroxyl-CoA dehydrogenase deficiency (LCHAD deficiency) [MIM:609016]: The clinical features are very similar to TFP deficiency. Biochemically, LCHAD deficiency is characterized by reduced long-chain 3-hydroxyl-CoA dehydrogenase activity, while the other enzyme activities of the TFP complex are normal or only slightly reduced. {ECO:0000269|PubMed:7811722, ECO:0000269|PubMed:9266371}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Maternal acute fatty liver of pregnancy (AFLP) [MIM:609016]: Severe maternal illness occurring during pregnancies with affected fetuses. This disease is associated with LCHAD deficiency and characterized by sudden unexplained infant death or hypoglycemia and abnormal liver enzymes (Reye-like syndrome). {ECO:0000269|PubMed:7846063}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.516
Intolerance Scores
- LoFtool
- 0.347
- RVIS EVS
- -0.64
- RVIS percentile EVS
- 16.63
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.958
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |